SpyGlass Pharma (SGP US): Synthetic Expert Call Transcript (05 Aug 2026)
Zero Workflow Friction is the Core Adoption Catalyst: Unlike micro-invasive glaucoma surgery (MIGS) or other drug-eluting platforms, SpyGlass...
120 Views
SpyGlass Pharma (SGP): Six Months Later: Strong Debut Holds Above Water as Investors Await Data
​SpyGlass Pharma's strong IPO debut reflects high demand for its innovative glaucoma and cataract treatment platform, with potential for future...
107 Views
SpyGlass Pharma Inc (SGP): Med-Tech Vision Pays Off: SpyGlass Pharma IPO Pops on Day One
​SpyGlass Pharma's IPO priced at $16.00, closed at $26.40 (+65%), oversubscribed deal with strong investor support, backed by top-tier investors...
311 Views
SpyGlass Pharma Inc (SGP): IPO Draws Demand as Med-Tech Story Gains Traction
​SpyGlass Pharma's oversubscribed IPO offers innovative BIM-IOL System for cataract surgery with glaucoma treatment, backed by top investors and...
443 Views
IPO Rating: Spyglass Pharma Inc.
✅ IPO PROPHET RATING: 7.6/10 🏦 Deal Quality & Underwriters: 8.2/10 Spyglass Therapeutics is preparing to list on the Nasdaq under the ticker...
270 Views